In the course of a screening for new antitumor antibiotics, we isolated six structurally related compounds from a culture broth of Streptomyces sp. Among them, GEX1Q1, GEX1Q2, GEX1Q3, GEX1Q4 and GEX1Q5 are novel compounds. The major product, GEX1A was identified as a known herbicide, herboxidiene1). In this paper, the taxonomy of the producing strain, fermentation, isolation, and antitumor properties of GEX1 compounds are described. The structure determination of GEX1Q1-Q5 will be reported in elsewhere. Materials and Methods
Microorganism
The producing strain GEX1 compounds was isolated from a soil sample collected in Yamanashi prefecture, transplanted into the abdomen of BALB/c-nu/nu mouse (nude mouse) by using a trocar. Eleven days after the transplantation, the growth of the tumor was confirmed. As concerns mouse tumor, a murine sarcoma 180 and murine SV-T2 were inoculated sc into ddY mice and BALB/c mice on day 0, respectively. Then test drug was iv administered indicated in Table 5 . The antitumor effect was determined in the following manner. The major axis and the minor axis of tumor are measured with calipers and the tumor volume was calculated in accordance with the formula ((major terms of the ratio (TIC) of the tumor volume of the tested group (T) to the tumor volume of the control group (C) to which no drug was administered.
Results

Characterization of the Producing Microorganisms
The cultural characteristics of strain GEX1 on various agar media are shown in Table 1 (Table 1) . No fragmentation of substrate mycelia was observed, and sclerotia, sporangia, or flagellated spores were not formed. The colors of substrate mycelia showed pale yellow to brown on the tested agar media. The aerial mycelium grew well and formed linear or curvaceous spiral was smooth. The physiological characteristics of strain GEX1 is shown in Table 2 . Analysis of whole-cell hydrolysates of the strain revealed that the cell walls contained L,L-diaminopimelic acid, and the major quinone components were hexahydrogenated menaquinone 9. These taxonomic observations indicate that the strain GEX1 belongs to the genus Streptomyces.
Isolation and Purification
The isolation scheme is shown in Fig. 2 . The major compound of the active components is named GEX1A. The other active components were named GEX1Q1-Q5 for THE JOURNAL OF ANTIBIOTICS 857 the order of the elution from ODS HPLC column. As mentioned below, GEX1Q3 was not stable in methanol, so methanol was not used for elution of active components.
The culture broth obtained as described in "Materials and GEX1Q1, GEX1Q2, GEX1Q4 and GEX1Q5, and a fraction containing GEX1A with high purity. Each fraction except a fraction containing GEX1A was passed through a reverse phase column packed with ODS-AM 120-230/70 (150ml, YMC Inc.) to adsorb the active components, and the column was washed with 20% aqueous acetonitrile containing 10mM sodium acetate to remove the impurities.
Then, the active components were eluted with 30% and 40% aqueous acetonitrile containing 10mM sodium acetate and fractionated. The active fractions thus eluated were concentrated, thus were obtained a fraction consisting essentially of GEX1Q1; a fraction consisting essentially of GEX1Q1, GEX1Q3; a fraction consisting essentially of GEX1Q2, GEX1Q4; a fraction consisting essentially of GEX1Q4; and a fraction consisting essentially of GEX1Q5. Each fraction was subjected to a reverse phase preparative HPLC using a packed column (SH343-5, and desalted, and the active substance was eluted with acetonitrile, and concentrated to dryness to obtain finally 46mg of GEX1Q1, 87mg of GEX1Q2, 8.3mg of GEX1Q3, 73mg of GEX1Q4 and 24mg of GEX1Q5. The HP-20SS fraction containing GEX1A with high purity was subjected to a column chromatography on silica gel Lichroprep Si60 (150ml, Merck). After developed with 4% methanol-chloroform (0.5% stepwise) and fractionated, the active fractions are concentrated to dryness to obtain 0.6g of GEX1A.
Structures of GEX1 Compounds
The physicochemical properties of GEX1 compounds are shown in Table 3 . On the basis of the analysis of a variety of the spectra, the structures of GEX1 compounds were determined as shown in Fig. 3 . GEX1A was identified to herboxidiene1) which was reported as a potent, selective herbicide against a variety of weed species and wheat1).
Herboxidiene was structurally interesting because of the tetrahydropyran moiety and the side chain including conjugated diene5-7). GEX1Q1 was hydroxylated derivative Table 3 . Physico-chemical properties of GEX1 compounds. at tetrahydropyran moiety of herboxidiene. GEX1Q2 and GEX1Q4 were hydroxylated derivatives at the side chain of herboxidiene. GEX1Q3 was glucuronide of herboxidiene.
GEX1Q5 had an additional hydroxy group instead of the methoxy group of other GEX1 compounds. Among six GEX1 compounds, only GEX1Q3 was soluble in water.
Details of structural elucidation studies will be described elsewhere.
Antimicrobial Activity
The antimicrobial activities of GEX1 compounds were estimated by a 2-fold serial dilution method. All GEX1 In Vitro Cytotoxicity
As shown in GEX1A/herboxidiene showed the one-fourth to one-second times lower IC50 value than that of GEX1Q5, and as one-tenth times as GEX1Q3 against all four cell lines tested (Table 4 ).
In Vivo Antitumor Activity
In vivo antitumor effect of GEX1A/herboxidiene, GEX1Q3 and GEX1Q5 against murine tumors and human tumor were examined in the mouse models. Against the SV-T2 murine fibrosarcoma, when administered by single intraperitoneally injection on day 0, GEX1A/herboxidiene showed significant antitumor activity (T/C 0.47) on day 4 at dose of 1mg/kg (Table 5) . By consecutive injection of GEX1A/herboxidiene (0.13mg/kg), four of five mice died within 11 days. No significant antitumor effects of GEX1A/herboxidiene, GEX1Q3, GEX1Q5 were detected both in the murine sarcoma 180 model and in the human tumor A549 xenograft model. Mice injected with these three compounds exhibited a weight-loss within 7 days but then recovered. In all the case of died mice injected with GEX1A/herboxidiene, decreases in white blood cells and platelets were observed on day 4 (data not shown).
Discussion
GEX1A/herboxidiene showed most effective cytotoxicity among the GEX1 compounds. The effect of GEX1Q5, which have the hydroxy group in spite of methoxy group near the end of side chain of GEX1A/herboxidiene, was as one third times weak as GEX1A/herboxidiene. GEX1Q2, GEX1Q4 and GEX1Q1, which possess a hydroxy group near the diene moiety or tetrahydropyran, showed dramatically weaker activity, suggesting these moieties are critical to the cytotoxicities.
GEX1A/herboxidiene showed antitumor effect against murine SV-T2 by single injection. TAN-1609, the identical compound with GEX1A/herboxidiene, was reported in patent8) to inhibit murine colon 26 and M5076. GEX1A/herboxidiene and related compounds showed hematotoxicities in vivo in this paper. It is necessary to increase selective cytotoxicity to tumor cells for development of these compounds as clinical drugs for cancer therapy.
To elucidate the mode of action of GEX1 compounds, we analyzed the effect of these drugs on cell cycle progression and on the expression of various genes9). In the course of the analysis, GEX1 compounds were shown to activate gene expression in various reporter cells. Details of these biological activities are described in the succeeding paper9). a Compounds were administered i.v., by single injection on day 0(x1), or consecutive injection on day 0-4(x5). b T/C(%)<0.5 and p<0.01 by M ann-Whitney's U-test as compared with control group.
c Number of died mice on the day when antitumor activity was evaluated.
